Search Results - "Patriarca, Peter"

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older by Dunkle, Lisa M, Izikson, Ruvim, Patriarca, Peter, Goldenthal, Karen L, Muse, Derek, Callahan, Janice, Cox, Manon M.J

“…Influenza epidemics cause substantial morbidity. The seasonal vaccine, an important control measure, is not completely efficacious. This trial assessed the…”
Get full text

Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience by Nicolay, Uwe, Heijnen, Esther, Nacci, Pantaleo, Patriarca, Peter A., Leav, Brett

“…•A meta-analysis of influenza vaccine trials spanning 21 years was conducted.•Antibody responses are significantly higher with aIIV3 than IIV3 in the…”
Get full text

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age by Dunkle, Lisa M., Izikson, Ruvim, Patriarca, Peter A., Goldenthal, Karen L., Muse, Derek, Cox, Manon M. J.

“…Randomized comparison of immunogenicity and safety of quadrivalent recombinant versus inactivated vaccine in young adults showed overall comparable antibody…”
Get full text

Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial by Dunkle, Lisa M, Izikson, Ruvim, Patriarca, Peter A, Goldenthal, Karen L, Cox, Manon, Treanor, John J

“…The recombinant influenza vaccine is well established in adults ≥18 years of age for preventing seasonal influenza disease. In this randomized controlled…”
Get full text

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok® ) against influenza in healthy adults: A randomized, placebo-controlled trial by Treanor, John J, Sahly, Hana El, King, James, Graham, Irene, Izikson, Ruvim, Kohberger, Robert, Patriarca, Peter, Cox, Manon

“…Highlights ► Randomized, placebo-controlled, multicenter assessment of efficacy of baculovirus expressed hemagglutinin vaccine for prevention of…”
Get full text

Integrating Electronic Medical Records and Claims Data for Influenza Vaccine Research by Boikos, Constantina, Imran, Mahrukh, De Lusignan, Simon, Ortiz, Justin R, Patriarca, Peter A, Mansi, James A

“…Real-world evidence (RWE) increasingly informs public health and healthcare decisions worldwide. A large database has been created (“Integrated Dataset”) that…”
Get full text

Expert Review on Poliovirus Immunity and Transmission by Duintjer Tebbens, Radboud J., Pallansch, Mark A., Chumakov, Konstantin M., Halsey, Neal A., Hovi, Tapani, Minor, Philip D., Modlin, John F., Patriarca, Peter A., Sutter, Roland W., Wright, Peter F., Wassilak, Steven G. F., Cochi, Stephen L., Kim, Jong-Hoon, Thompson, Kimberly M.

“…Successfully managing risks to achieve wild polioviruses (WPVs) eradication and address the complexities of oral poliovirus vaccine (OPV) cessation to stop all…”
Get full text

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age by Izikson, Ruvim, Leffell, David J, Bock, S. Allan, Patriarca, Peter A, Post, Penny, Dunkle, Lisa M, Cox, Manon M.J

“…Abstract Background The safety and tolerability of Flublok® , a purified recombinant hemagglutinin seasonal influenza vaccine, was compared to AFLURIA® in a…”
Get full text

FluBlok, a recombinant hemagglutinin influenza vaccine by Cox, Manon M.J., Patriarca, Peter A., Treanor, John

“…FluBlok, a recombinant trivalent hemagglutinin (HA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive…”
Get full text

Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs by Duintjer Tebbens, Radboud J., Pallansch, Mark A., Chumakov, Konstantin M., Halsey, Neal A., Hovi, Tapani, Minor, Philip D., Modlin, John F., Patriarca, Peter A., Sutter, Roland W., Wright, Peter F., Wassilak, Steven G.F., Cochi, Stephen L., Kim, Jong-Hoon, Thompson, Kimberly M.

“…With the intensifying global efforts to eradicate wild polioviruses, policymakers face complex decisions related to achieving eradication and managing…”
Get full text

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group by Pavlinac, Patricia B, Rogawski McQuade, Elizabeth T, Platts-Mills, James A, Kotloff, Karen L, Deal, Carolyn, Giersing, Birgitte K, Isbrucker, Richard A, Kang, Gagandeep, Ma, Lyou-Fu, MacLennan, Calman A, Patriarca, Peter, Steele, Duncan, Vannice, Kirsten S

“…Vaccine candidates for are approaching phase 3 clinical trials in the target population of young children living in low- and middle-income countries. Key study…”
Get full text

Analysis of the Risks and Benefits of New Chemical Entities Approved by the US Food and Drug Administration (FDA) and Subsequently Withdrawn From the US Market by Patriarca, Peter A, Van Auken, R Michael, Kebschull, Scott A

“…Benefit-risk evaluations of drugs have been conducted since the introduction of modern regulatory systems more than 50 years ago. Such judgments are typically…”
Get more information

A Randomized Controlled Trial of Influenza Vaccine in the Elderly: Scientific Scrutiny and Ethical Responsibility by Patriarca, Peter A

“…Influenza viruses have arguably caused more morbidity and mortality than any infectious agent in recorded history. Seven pandemics of influenza have occurred…”
Get full text

Influenza Pandemic Preparedness Plan for the United States by Patriarca, Peter A., Cox, Nancy J.

“…In preparation for the next influenza pandemic, a comprehensive and action-oriented plan is presently under development that focuses on six major areas: (1)…”
Get full text

Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. (the Kaiser Permanente Measles Vaccine Trial Team) by Markowitz, Lauri E, Albrecht, Paul, Rhodes, Philip, Demonteverde, Ruth, Swint, Emmett, Maes, Edmond F, Powell, Clydette, Patriarca, Peter A

“…Objectives. In the United States, younger women are more likely to have immunity to measles from vaccination and are less likely to have been exposed to the…”
Get full text

Preparing for pandemic influenza: the need for enhanced surveillance by Gensheimer, Kathleen F, Fukuda, Keiji, Brammer, Lynette, Cox, Nancy, Patriarca, Peter A, Strikes, Raymond A

“…In the US, planning for the next influenza pandemic is occurring in parallel at the national, state and local levels. Certain issues, such as conducting…”
Get full text

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE + GLA) adjuvant by Treanor, John J, Essink, Brandon, Hull, Steven, Reed, Steven, Izikson, Ruvim, Patriarca, Peter, Goldenthal, Karen L, Kohberger, Robert, Dunkle, Lisa M

“…Highlights • We evaluated baculovirus-expressed recombinant H5 hemagglutinin vaccine with the adjuvant GLE/SE. • Adjuvanted vaccine was substantially more…”
Get full text

Report of a US Public Health Service Workshop on Hypotonic-Hyporesponsive Episode (HHE) After Pertussis Immunization by Braun, M. Miles, Terracciano, Gina, Salive, Marcel E, Blumberg, Dean A, Vermeer-de Bondt, Patricia E, Heijbel, Harald, Evans, Geoffrey, Patriarca, Peter A, Ellenberg, Susan S

“…Hypotonic-hyporesponsive episode (HHE) is a term used to describe a somewhat heterogenous group of clinical disorders that have been reported primarily in…”
Get full text

Influenza Vaccine for Healthy Adults? by Patriarca, Peter A, Strikas, Raymond A

“…Of all the preventive measures available to practitioners today, few are as medically and economically compelling as vaccination against influenza. The disease…”
Get full text

EDITORIAL COMMENTARY: Research and Development and the Polio Eradication Initiative: Too Much, Too Soon ... Too Little, Too Late? by Patriarca, Peter A.

Get full text